Souhaitez-vous accéder aux communiqués récents ?

Kneat shareholders overwhelmingly support transaction with Thoma Bravo in special meeting vote.

Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services.

LOS ALTOS, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cheiron, the operating system for drug programs, today announced an $8 million seed round led by Menlo Ventures, with the backing and strategic...

Capital-efficient strategy focuses on differentiated therapies for cardiac pre- and post-operative critical care and orphan cardiovascular conditionsCompany is exploring development, licensing, and...

MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the...

Proposed acquisition of Kneat by Thoma Bravo provides significant, immediate, and certain value to shareholders after months-long strategic review process

Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki...

Pharmaceutical executive brings 25+ years of international commercial leadership and rare disease experience Egham, UK – 18 June 2026 – Essential Pharma ("Essential" or "the Company"), a global...

OTCID:MAJI announced a strategic pivot, evolutionary restructuring, and operational alignment designed to transition the company

New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated...